Hans Garmo

New England Journal of Medicine · 2008–2014

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from Hans Garmo's perspective

Ordered by how strongly the researchers Hans Garmo trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Unintended medication discrepancies at the time of hospital admission. (Archives of Internal Medicine)
  2. Gentleman R: R: A language for data analysis and graphics
  3. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. (Archives of Internal Medicine)
  4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. (New England Journal of Medicine)
  5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  6. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes (Nature Genetics)
  7. A common variant associated with prostate cancer in European and African populations (Nature Genetics)
  8. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
  9. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke (Nature Genetics)
  10. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. (Journal of the American Medical Association (JAMA))

Their papers